Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification
Cancer Medicine · 2023
DOI: 10.1002/cam4.5877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Masanori Nakamura und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: Ampulla of Vater, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenocarcinoma. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Small intestine carcinoma (SIC) cases in Japan have recently been treated with chemotherapy according to colorectal carcinoma classification, while papilla of Vater carcinoma (PVC) cases according to cholangiocarcinoma (CHC) classification. However, few research reports support the molecular genetic validity of these therapeutic choices. Patients and methods Here, we investigated the clinicopathological and molecular genetic factors of SIC and PVC. We used the data from the Japanese version of The Cancer Genome Atlas. Additionally, molecular genetic data on gastric adenocarcinoma (GAD), colorectal adenocarcinoma (CRAD), pancreatic ductal adenocarcinoma (PDAC), and CHC were also referred to.
Results
This study consisted of tumor samples from 12 patients of SIC and three patients of PVC treated from January 2014 to March 2019. Among them, six patients had pancreatic invasion. t ‐Distributed stochastic neighbor embedding analysis showed that the gene expression pattern of SIC was similar not only to those of GAD and CRAD, but also to that of PDAC in the pancreatic invasion patients. In addition, PVC resembled the GAD, CRAD, and PDAC, rather than the CHC. The molecular genetic characteristics of the six patients with pancreatic invasion were: one had high microsatellite instability, two had a TP53 driver mutation, and three had tumor mutation burden values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
- Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Division of Digestive Surgery, Department of Surgery, Nihon University School of Medicine, Tokyo, Japan.
- Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
- Division of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
ORCID-Profile: Yukiyasu Okamura, Keiichi Ohshima, Akio Shiomi
Zitieren
APA
Nakamura, M., Okamura, Y., Ohshima, K., Sugiura, T., Ashida, R., Ohgi, K., Bando, E., Fujiya, K., Shiomi, A., Kagawa, H., Imamura, T., Nakayama, G., Kodera, Y., Uesaka, K., Ohike, N., Norose, T., Sasaki, K., Sugino, T., Ohnami, S., …, & Yamaguchi, K. (2023). Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification. Cancer Medicine. https://doi.org/10.1002/cam4.5877
Vancouver
Nakamura M, Okamura Y, Ohshima K, Sugiura T, Ashida R, Ohgi K, et al. Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification. Cancer Medicine. 2023. doi:10.1002/cam4.5877
BibTeX
@article{Nakamura2023,
author = {Nakamura, Masanori and Okamura, Yukiyasu and Ohshima, Keiichi and Sugiura, Teiichi and Ashida, Ryo and Ohgi, Katsuhisa and Bando, Etsuro and Fujiya, Keiichi and Shiomi, Akio and Kagawa, Hiroyasu and Imamura, Taisuke and Nakayama, Goro and Kodera, Yasuhiro and Uesaka, Katsuhiko and Ohike, Nobuyuki and Norose, Tomoko and Sasaki, Keiko and Sugino, Takashi and Ohnami, Sumiko and Nagashima, Takeshi and Urakami, Kenichi and Akiyama, Yasuto and Yamaguchi, Ken},
title = {Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5877}
}
EUVIMED